Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: The treatment in morning versus evening (TIME) study
This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in...
Uloženo v:
| Vydáno v: | Journal of human hypertension Ročník 36; číslo 12; s. 1099 - 1105 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Nature Publishing Group
01.12.2022
|
| Témata: | |
| ISSN: | 0950-9240, 1476-5527, 1476-5527 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in adults with hypertension. Participants reporting HBPM ownership were invited to submit blood pressure (BP) measurements three-monthly. Factors associated with active participation (submitting at least one set of BP measurements), and longer-term commitment (at least six sets of BP measurements), were analysed using multivariable logistic regression. 11,059 participants agreed to provide BP measurements, of whom 7646 submitted. Active participation was associated with age (adjusted odds ratio (AOR) per decade, 1.29; 95% CI 1.23-1.36), positive family history of hypertension (AOR 1.11; 95% CI 1.01-1.21), number of antihypertensive medications (AOR, 1.10; 95% CI 1.04-1.16), and lower deprivation (AOR per decile, 1.03; 95% CI 1.01-1.05). People with higher body mass index (BMI) and smokers were less likely to participate (AOR, 0.91 (per increase of 5.0 kg/m
) and 0.63 respectively; all p < 0.001). 3,655 participants (47.8%) submitted measurements beyond one year. Non-modifiable risk factors - age (AOR per decade, 1.29; 95% CI 1.21-1.37) and positive family history of hypertension (AOR, 1.15; 95% CI 1.03-1.27) - were positively associated with longer-term commitment. Higher BMI (AOR per 5.0 kg/m
, 0.89; 95% CI 0.85-0.93), smoking (AOR 0.60, 95% CI 0.44-0.82) and higher baseline systolic blood pressure (AOR per mmHg, 0.99; 95% CI 0.98-0.99) were negatively associated. This study provides insight into factors that influence HBPM use. |
|---|---|
| AbstractList | This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in adults with hypertension. Participants reporting HBPM ownership were invited to submit blood pressure (BP) measurements three-monthly. Factors associated with active participation (submitting at least one set of BP measurements), and longer-term commitment (at least six sets of BP measurements), were analysed using multivariable logistic regression. 11,059 participants agreed to provide BP measurements, of whom 7646 submitted. Active participation was associated with age (adjusted odds ratio (AOR) per decade, 1.29; 95% CI 1.23-1.36), positive family history of hypertension (AOR 1.11; 95% CI 1.01-1.21), number of antihypertensive medications (AOR, 1.10; 95% CI 1.04-1.16), and lower deprivation (AOR per decile, 1.03; 95% CI 1.01-1.05). People with higher body mass index (BMI) and smokers were less likely to participate (AOR, 0.91 (per increase of 5.0 kg/m
) and 0.63 respectively; all p < 0.001). 3,655 participants (47.8%) submitted measurements beyond one year. Non-modifiable risk factors - age (AOR per decade, 1.29; 95% CI 1.21-1.37) and positive family history of hypertension (AOR, 1.15; 95% CI 1.03-1.27) - were positively associated with longer-term commitment. Higher BMI (AOR per 5.0 kg/m
, 0.89; 95% CI 0.85-0.93), smoking (AOR 0.60, 95% CI 0.44-0.82) and higher baseline systolic blood pressure (AOR per mmHg, 0.99; 95% CI 0.98-0.99) were negatively associated. This study provides insight into factors that influence HBPM use. This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in adults with hypertension. Participants reporting HBPM ownership were invited to submit blood pressure (BP) measurements three-monthly. Factors associated with active participation (submitting at least one set of BP measurements), and longer-term commitment (at least six sets of BP measurements), were analysed using multivariable logistic regression. 11,059 participants agreed to provide BP measurements, of whom 7646 submitted. Active participation was associated with age (adjusted odds ratio (AOR) per decade, 1.29; 95% CI 1.23-1.36), positive family history of hypertension (AOR 1.11; 95% CI 1.01-1.21), number of antihypertensive medications (AOR, 1.10; 95% CI 1.04-1.16), and lower deprivation (AOR per decile, 1.03; 95% CI 1.01-1.05). People with higher body mass index (BMI) and smokers were less likely to participate (AOR, 0.91 (per increase of 5.0 kg/m2) and 0.63 respectively; all p < 0.001). 3,655 participants (47.8%) submitted measurements beyond one year. Non-modifiable risk factors - age (AOR per decade, 1.29; 95% CI 1.21-1.37) and positive family history of hypertension (AOR, 1.15; 95% CI 1.03-1.27) - were positively associated with longer-term commitment. Higher BMI (AOR per 5.0 kg/m2, 0.89; 95% CI 0.85-0.93), smoking (AOR 0.60, 95% CI 0.44-0.82) and higher baseline systolic blood pressure (AOR per mmHg, 0.99; 95% CI 0.98-0.99) were negatively associated. This study provides insight into factors that influence HBPM use.This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in adults with hypertension. Participants reporting HBPM ownership were invited to submit blood pressure (BP) measurements three-monthly. Factors associated with active participation (submitting at least one set of BP measurements), and longer-term commitment (at least six sets of BP measurements), were analysed using multivariable logistic regression. 11,059 participants agreed to provide BP measurements, of whom 7646 submitted. Active participation was associated with age (adjusted odds ratio (AOR) per decade, 1.29; 95% CI 1.23-1.36), positive family history of hypertension (AOR 1.11; 95% CI 1.01-1.21), number of antihypertensive medications (AOR, 1.10; 95% CI 1.04-1.16), and lower deprivation (AOR per decile, 1.03; 95% CI 1.01-1.05). People with higher body mass index (BMI) and smokers were less likely to participate (AOR, 0.91 (per increase of 5.0 kg/m2) and 0.63 respectively; all p < 0.001). 3,655 participants (47.8%) submitted measurements beyond one year. Non-modifiable risk factors - age (AOR per decade, 1.29; 95% CI 1.21-1.37) and positive family history of hypertension (AOR, 1.15; 95% CI 1.03-1.27) - were positively associated with longer-term commitment. Higher BMI (AOR per 5.0 kg/m2, 0.89; 95% CI 0.85-0.93), smoking (AOR 0.60, 95% CI 0.44-0.82) and higher baseline systolic blood pressure (AOR per mmHg, 0.99; 95% CI 0.98-0.99) were negatively associated. This study provides insight into factors that influence HBPM use. This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a remote clinical trial assessing the effectiveness of morning vs. evening dosing of antihypertensive medications on cardiovascular outcomes in adults with hypertension. Participants reporting HBPM ownership were invited to submit blood pressure (BP) measurements three-monthly. Factors associated with active participation (submitting at least one set of BP measurements), and longer-term commitment (at least six sets of BP measurements), were analysed using multivariable logistic regression. 11,059 participants agreed to provide BP measurements, of whom 7646 submitted. Active participation was associated with age (adjusted odds ratio (AOR) per decade, 1.29; 95% CI 1.23–1.36), positive family history of hypertension (AOR 1.11; 95% CI 1.01–1.21), number of antihypertensive medications (AOR, 1.10; 95% CI 1.04–1.16), and lower deprivation (AOR per decile, 1.03; 95% CI 1.01–1.05). People with higher body mass index (BMI) and smokers were less likely to participate (AOR, 0.91 (per increase of 5.0 kg/m2) and 0.63 respectively; all p < 0.001). 3,655 participants (47.8%) submitted measurements beyond one year. Non-modifiable risk factors – age (AOR per decade, 1.29; 95% CI 1.21–1.37) and positive family history of hypertension (AOR, 1.15; 95% CI 1.03–1.27) – were positively associated with longer-term commitment. Higher BMI (AOR per 5.0 kg/m2, 0.89; 95% CI 0.85–0.93), smoking (AOR 0.60, 95% CI 0.44–0.82) and higher baseline systolic blood pressure (AOR per mmHg, 0.99; 95% CI 0.98–0.99) were negatively associated. This study provides insight into factors that influence HBPM use. |
| Author | MacDonald, Thomas M Anbarasan, Thineskrishna Rogers, Amy Rorie, David A Mackenzie, Isla S Vickneson, Keeran |
| Author_xml | – sequence: 1 givenname: Keeran orcidid: 0000-0002-2413-4770 surname: Vickneson fullname: Vickneson, Keeran organization: Medical Student, Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK – sequence: 2 givenname: Amy orcidid: 0000-0001-5207-7032 surname: Rogers fullname: Rogers, Amy email: a.rogers@dundee.ac.uk organization: Clinical Research Fellow, Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK. a.rogers@dundee.ac.uk – sequence: 3 givenname: Thineskrishna surname: Anbarasan fullname: Anbarasan, Thineskrishna organization: Medical Student, Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK – sequence: 4 givenname: David A surname: Rorie fullname: Rorie, David A organization: BHF Senior Software Developer, Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK – sequence: 5 givenname: Thomas M surname: MacDonald fullname: MacDonald, Thomas M organization: Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK – sequence: 6 givenname: Isla S surname: Mackenzie fullname: Mackenzie, Isla S organization: Medicines Monitoring Unit (MEMO Research), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34667251$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkc1OHSEUgEljo9efF-iiIenGLqYFBgamO2PUmth0c11PEA63GH6mwJj4Yn2-zq124-IcODkfX044x-gg5QQIfaDkCyW9-lo57SXtCFuDDGsW79CGcjl0QjB5gDZkFKQbGSdH6LjWR0L2TXWIjno-DJIJukF_rrVpuVTskwsLJOPTDs-6NG_8rJvPCetkcchp1zUoEZsco28RUsMt4wrBdTEnvzr2L7PDDyFni-cCtS4FVi_WOOiyA1wg5gbYBJ-80QG34nX4hre_YL2CfpGufMwl7WVPUOpSMTzBv_J8e_vj6jOubbHPp-i906HC2et5gu6vr7aX37u7nze3lxd3nRGctG5Ug1NKOzsOTiireg6aCmnYqLim3BE5MrBOMqfdQEhvrSLGSAXaOjEQ2Z-g8xfvXPLvBWqboq8GQtAJ8lInJhRff5WO_Yp-eoM-5qWkdbqJSa4GPjK2pz6-UstDBDvNxUddnqf_G-n_Aj09kwk |
| CitedBy_id | crossref_primary_10_1016_j_jcpo_2024_100494 crossref_primary_10_1080_07420528_2023_2253288 crossref_primary_10_1016_S0140_6736_22_01786_X crossref_primary_10_1093_ajh_hpae085 crossref_primary_10_1080_17512433_2024_2304015 crossref_primary_10_1097_HJH_0000000000003628 crossref_primary_10_2196_38900 |
| ContentType | Journal Article |
| Copyright | 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1038/s41371-021-00621-5 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1476-5527 |
| EndPage | 1105 |
| ExternalDocumentID | 34667251 |
| Genre | Clinical Trial Journal Article |
| GrantInformation_xml | – fundername: British Heart Foundation grantid: CS/14/1/30659 |
| GroupedDBID | --- -Q- 0R~ 29K 2WC 36B 39C 4.4 406 53G 5GY 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 A8Z AACDK AANZL AASML AATNV AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABDBF ABFSG ABJNI ABLJU ABOCM ABRTQ ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ATHPR AXYYD AYFIA B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF D-I DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS ECM EE. EIF EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 L7B M1P M7P NPM NQJWS O9- OK1 OVD P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP W2D YYP ZXP ~8M 3V. 7T5 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c540t-986f88afd96f58d834ea157c2984a14f0792edf72faf6003dd80cc78eadf56073 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708780900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0950-9240 1476-5527 |
| IngestDate | Sun Nov 09 13:26:05 EST 2025 Mon Oct 06 17:24:00 EDT 2025 Mon Jul 21 06:03:15 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | 2021. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-986f88afd96f58d834ea157c2984a14f0792edf72faf6003dd80cc78eadf56073 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ORCID | 0000-0002-2413-4770 0000-0001-5207-7032 |
| OpenAccessLink | https://link.springer.com/article/10.1038/s41371-021-00621-5 |
| PMID | 34667251 |
| PQID | 2748649223 |
| PQPubID | 35973 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2584014193 proquest_journals_2748649223 pubmed_primary_34667251 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-12-01 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Journal of human hypertension |
| PublicationTitleAlternate | J Hum Hypertens |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group |
| SSID | ssj0014768 |
| Score | 2.4046922 |
| Snippet | This study investigates factors associated with active participation, and long-term commitment, to home blood pressure monitoring (HBPM) in the TIME study, a... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1099 |
| SubjectTerms | Adult Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Antihypertensives Blood Pressure Blood Pressure Monitoring, Ambulatory Body mass index Body measurements Clinical trials Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - epidemiology Participation Risk Factors |
| Title | Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: The treatment in morning versus evening (TIME) study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34667251 https://www.proquest.com/docview/2748649223 https://www.proquest.com/docview/2584014193 |
| Volume | 36 |
| WOSCitedRecordID | wos000708780900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDBbWdhh26d5r1zbggB22g1DFsk15l2IrEmyHBMHQAbkFih5DgMRO46Q_rb-vlKJku2yXHSzAsCAbEE19JD-SjH1AYaVHozh6RQaKsl1OKKPgrsj01BopvRWx2QQOh2o8rkbJ4dYmWuVOJ0ZFbRsTfOSXZD2pMq_oNLta3vLQNSpEV1MLjQN2FKokyEjdG-2jCDnGVDhCEYKTnSFS0oyQ6rIl5Y1kSGd0iZLG4u8QMx41_Wf_-5HP2XECmfBlKxUv2CNXv2RPBimM_ord97dddmCWWpTQ-QVL_QfDGnRtYd7Uv3hQ3UBvX8wiHx3WDbRu7vkiKoPgFYTGQ-S_QyTVblaO1gUN80Ayh5UjYXCwy8CE2CbkM5B4wp7kHuYvmuiigUAT2bQQCkuF24833we9TxCr4L5mP_u9m-tvPDVw4IaA4JpXqvRKaW-r0hfKKpk73S3QZJXKdTf3AqvMWY-Z156Al7RWCWNQkXR7QmIo37DDuqndCYOQsDvFwnSLKeYaXWWdk144sqBoLVSn7Hy3I5P0F7aT39txyt7vH9P_E4IiunbNhuYQAgtk14rmvN3u-mS5LfQxkXlZIgHAd_9e_Iw9zUJSRCS5nLPD9WrjLthjc7eetasOO8AxxlF12NHX3nD0oxPFlMbhaPAA1TzxcA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwEB4tCwIuvB8LCwwSSHCwNomT2EFCCMFWW-224lCk3oLrB6rUJqVpQfwpjvw-xk5SuMBtDxwSKbI1UuzxzDf2Nx6AZyIy3AktmXCSAhRpYkYoI2M2S9TMaM6diUKxCTEey-m0-LAHP_pcGE-r7G1iMNSm1n6P_IiiJ5mnBXmzN6svzFeN8qerfQmNVi1O7fdvFLI1r4fvaX6fJ8ngePLuhHVVBZgmdLJhhcydlMqZIneZNJKnVsWZ0EkhUxWnLhJFYo0TiVOO0AA3RkZaC0lD7ggeCE5yL8BFsuPCU8jEdBfgxakIqXeEWiJGcU3UJelEXB415CwEBe4JPVFO7-zvkDa4tsH1_21QbsC1DkTj21brb8KerW7B5VFHE7gNPwdtFSGcdyVYyD_jSv3BIEdVGVzU1WfmXRPS3y7ngW-Pmxobu3BsGYyd3_XE2mHg92MgDW_XluSiwoUn0ePakrJb7DNMMZRBeYW0_HBH4vf9l3XYgkJPg9k26C_O8p8vJsPR8UsMt_zegY_nMmp3Yb-qK3sf0Cckz0Sm42wmUiVsYazlLrIUIZIsIQ_gsNeAsrMyTfl7-g_g6a6Z7IM_9FGVrbfUhxCmJ_MW1Odeq2Xlqr3IpORpngsCuA_-LfwJXDmZjM7Ks-H49CFcTXwCSCD0HML-Zr21j-CS_rqZN-vHYTkgfDpvVfsFnrRKmA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwELaWBa248H4sLDBIIMHBqhsnGWelFULsVlRLqx4WaW_BjW1UqU1K04L4Yxz21-3YSQoXuO2BQyJFsUaKM49v7G88jL1CYaTDQnF0ihIUZfqcUEbCbRLpqSmkdEaEZhM4Hqvz82yywy66WhhPq-x8YnDUpir8GnmPsieVxhlFs55raRGT48G75TfuO0j5ndaunUajIqf25w9K3-qj4TH969dRNDg5-_CRtx0GeEFIZc0zlTqltDNZ6hJllIyt7idYRJmKdT92ArPIGoeR046QgTRGiaJARdPvCCqgJLnX2HWM0-AURjjZ7mDEGMrwCMEITjmOaAt2hFS9mgIHUhIf0SVSuid_h7chzA1u_88TdIfdasE1vG-s4S7bseU9tjdq6QP32a9B010IZm1rForbsNR_MMtBlwbmVfmV-5AF9OWLWeDhw7qC2s4dXwQn6FdDoXIQeP8QyMSblSW5oGHuyfWwsmQEFrrKUwjtUQ6BzBK25H4_flGFpSnw9JhNDf5ALf_45mw4OnkL4fTfB-zzlczaQ7ZbVqV9zMAXKk8xKfrJFGONNjPWSicsZY4kC9U-O-i0IW-9T53_VoV99nL7mvyG3wzSpa02NIaQpyf5ZjTmUaNx-bI54CSXcZoiAd8n_xb-gu2RhuWfhuPTp-xm5OtCAs_ngO2uVxv7jN0ovq9n9ep5sAxgX65a0y4Bb6VTZw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+participation+and+long-term+commitment+to+self-monitoring+of+blood+pressure+in+a+large+remote+clinical+trial%3A+The+treatment+in+morning+versus+evening+%28TIME%29+study&rft.jtitle=Journal+of+human+hypertension&rft.au=Vickneson%2C+Keeran&rft.au=Rogers%2C+Amy&rft.au=Anbarasan%2C+Thineskrishna&rft.au=Rorie%2C+David+A&rft.date=2022-12-01&rft.pub=Nature+Publishing+Group&rft.issn=0950-9240&rft.eissn=1476-5527&rft.volume=36&rft.issue=12&rft.spage=1099&rft.epage=1105&rft_id=info:doi/10.1038%2Fs41371-021-00621-5&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9240&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9240&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9240&client=summon |